Start of the Einstein Center for Early Disease Interception

In its December meeting, the Board of the Einstein Foundation Berlin approved new research projects with a total funding of 13 million euros over the next six years.

Deadline: 13th February 2026

ProBioGen announced today the signing of a Master Service Agreement ("MSA") with Zag Bio, Inc., a biotechnology company developing thymus-targeted therapies to induce central immune tolerance.

Surprisingly, unmodified mRNA does not trigger an inflammatory response in T cells

Deadline: Februrary 1st 2026

Karen Christman, a Stiftung Charité Visiting Fellow at the Max Delbrück Center, is among the first researchers to have won a Humboldt Research Award under Germany’s Global Minds Initiative. The award will enable her to expand her research in Germany…

The Max Delbrück Center has recently completed construction of a new Demonstrator Lab as a testbed to reduce the environmental impact of biomedical research. The insights gained will be applied to all new building renovations across the center.

A team of researchers from Charité – Universitätsmedizin Berlin and the Max Delbrück Center has captured the fleeting moment a nerve cell releases its neurotransmitters into the synaptic cleft. Their microscopic images and description of the process…

Neurons in the cerebral cortex form subtypes that differ in function and connectivity